These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38360927)

  • 1. Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors.
    Wei X; Rigopoulos A; Lienhard M; Pöhle-Kronawitter S; Kotsaris G; Franke J; Berndt N; Mejedo JO; Wu H; Börno S; Timmermann B; Murgai A; Glauben R; Stricker S
    Nat Commun; 2024 Feb; 15(1):1393. PubMed ID: 38360927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
    Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
    Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.
    Stansfield BK; Bessler WK; Mali R; Mund JA; Downing BD; Kapur R; Ingram DA
    Am J Pathol; 2014 Jan; 184(1):79-85. PubMed ID: 24211110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromin (Nf1) is required for skeletal muscle development.
    Kossler N; Stricker S; Rödelsperger C; Robinson PN; Kim J; Dietrich C; Osswald M; Kühnisch J; Stevenson DA; Braun T; Mundlos S; Kolanczyk M
    Hum Mol Genet; 2011 Jul; 20(14):2697-709. PubMed ID: 21478499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.
    Wei X; Franke J; Ost M; Wardelmann K; Börno S; Timmermann B; Meierhofer D; Kleinridders A; Klaus S; Stricker S
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1758-1778. PubMed ID: 33078583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.
    Wang Y; Kim E; Wang X; Novitch BG; Yoshikawa K; Chang LS; Zhu Y
    Cell; 2012 Aug; 150(4):816-30. PubMed ID: 22901811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
    Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
    Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
    Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
    Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
    J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
    Anastasaki C; Gutmann DH
    Hum Mol Genet; 2014 Dec; 23(25):6712-21. PubMed ID: 25070947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by
    Perrin S; Protic S; Bretegnier V; Laurendeau I; de Lageneste OD; Panara N; Ruckebusch O; Luka M; Masson C; Maillard T; Coulpier F; Pannier S; Wicart P; Hadj-Rabia S; Radomska KJ; Zarhrate M; Ménager M; Vidaud D; Topilko P; Parfait B; Colnot C
    Sci Transl Med; 2024 Jun; 16(753):eadj1597. PubMed ID: 38924432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.
    House RRJ; Tovar EA; Redlon LN; Essenburg CJ; Dischinger PS; Ellis AE; Beddows I; Sheldon RD; Lien EC; Graveel CR; Steensma MR
    Mol Metab; 2024 Feb; 80():101876. PubMed ID: 38216123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
    Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
    Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways.
    Chen YH; Gianino SM; Gutmann DH
    Genes Dev; 2015 Aug; 29(16):1677-82. PubMed ID: 26272820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.
    Staser K; Park SJ; Rhodes SD; Zeng Y; He YZ; Shew MA; Gehlhausen JR; Cerabona D; Menon K; Chen S; Sun Z; Yuan J; Ingram DA; Nalepa G; Yang FC; Clapp DW
    J Clin Invest; 2013 Jan; 123(1):329-34. PubMed ID: 23221339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
    Dasgupta B; Dugan LL; Gutmann DH
    J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.